Literature DB >> 8903999

Noninvasive recording of His bundle activity with an analog delay device in normal subjects and patients with atrioventricular block.

Y Ushiyama1, H Okajima, Y Sasaki, M Hasegawa.   

Abstract

A simplified and clinically applicable method has been developed for real-time noninvasive recording of the electrical activity of the His bundle in the human heart. A surface electrocardiogram (ECG) was obtained from bipolar precordial leads. The electrical signal within the P-QRS segment of the ECG was amplified with a high gain amplifier and delayed with an analog delay device for QRS-triggered signal averaging. The analog delay device consisted of a bucket brigade device (BBD) with an electrical integrated circuit (IC). After filtering with a band width of 50-300 Hz, the delayed signal was processed by a microcomputer system and the signal-to-noise ratio of the signal was improved by the signal averaging technique. Surface His bundle electrocardiograms (SHE) were measured in normal subjects without conduction disorders and in patients with atrio-ventricular (A-V) block. In the same patients, each SHE was nonsimultaneously compared with an invasive His bundle electrogram (HBE) obtained by the intracardiac catheter technique. The results of this comparison confirmed that the noninvasive method of SHE recording has broad clinical applicability and high utility for the screening of patients with latent A-V block before intracardiac catheterization is performed.

Entities:  

Mesh:

Year:  1995        PMID: 8903999     DOI: 10.1007/bf01744903

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  20 in total

1.  Non-invasive recording of His bundle potential in man. Simplified method.

Authors:  Y Hishimoto; T Sawayama
Journal:  Br Heart J       Date:  1975-06

2.  The electrical activity of the bundle of His.

Authors:  J ALANIS; H GONZALEZ; E LOPEZ
Journal:  J Physiol       Date:  1958-06-18       Impact factor: 5.182

3.  Real-time method for noninvasive recording of His bundle activity of the electrocardiogram.

Authors:  T J vanden Akker; H H Ros; H G Goovaerts; H Schneider
Journal:  Comput Biomed Res       Date:  1976-12

4.  [Recording of the his bundle potential at the surface of the thorax in healthy volunteers. Application to the study of propranolol].

Authors:  M Biour; J Weissenburger; J M Poirier; J Y Le Heuzey; F Gay; P Cazaux; G Cheymol
Journal:  Therapie       Date:  1989 Jan-Feb       Impact factor: 2.070

5.  Surface recording of electrical activity from the region of the bundle of His.

Authors:  N C Flowers; R C Hand; P C Orander; C B Miller; M O Walden; L G Horan
Journal:  Am J Cardiol       Date:  1974-03       Impact factor: 2.778

6.  A study of heart block in man using His bundle recordings.

Authors:  A N Damato; S H Lau; R Helfant; E Stein; R D Patton; B J Scherlag; W D Berkowitz
Journal:  Circulation       Date:  1969-03       Impact factor: 29.690

7.  The feasibility of detecting His-bundle activity from the body surface.

Authors:  A Furness; G P SHARRATT; P Carson
Journal:  Cardiovasc Res       Date:  1975-05       Impact factor: 10.787

8.  Noninvasive recording of His-Purkinje activity in patients with complete atrioventricular block. Clinical application of an "automated discrimination circuit".

Authors:  H Takeda; K Kitamura; T Takanashi; T Tokuoka; H Hamamoto; T Katoh; I Niki; Y Hishimoto
Journal:  Circulation       Date:  1979-08       Impact factor: 29.690

9.  Analysis of PR subintervals in normal subjects and early studies in patients with abnormalities of the conduction system using surface His bundle recordings.

Authors:  N C Flowers; V Shvartsman; L G Horan; P Palakurthy; G S Sohi; M R Sridharan
Journal:  J Am Coll Cardiol       Date:  1983-11       Impact factor: 24.094

10.  The His-Purkinje electrocardiogram in man: an initial assessment of its uses and limitations.

Authors:  E J Berbari; B J Scherlag; N El-Sherif; B Befeler; J M Aranda; R Lazzara
Journal:  Circulation       Date:  1976-08       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.